AssetMark’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
Other funds holding COLL
AssetMark's COLL Position: Q3 2026 in Review
AssetMark increased its Collegium Pharmaceutical (COLL) stake by 19% in Q3 2026, buying an estimated $33.5K and bringing the position to 7,162 shares worth $156K. The position accounts for ﹤0.01% of the portfolio, ranked #1530.
AssetMark first reported a position in COLL in Q1 2022 and has held it in 19 quarters since. The position peaked at $218K in Q2 2026. 189 funds tracked by Wall St. Rank hold COLL as of Q3 2026.
- AssetMark held 7,162 shares of Collegium Pharmaceutical worth $156K as of Q3 2026.
- AssetMark bought 1,149 Collegium Pharmaceutical shares in Q3 2026, an estimated $33.5K.
- Collegium Pharmaceutical made up ﹤0.01% of AssetMark's portfolio in Q3 2026, its #1530 holding.
- AssetMark first reported a position in Collegium Pharmaceutical in Q1 2022 and has held it in 19 quarters since.
- AssetMark's Collegium Pharmaceutical position peaked at $218K in Q2 2026.
- 189 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q3 2026.
Based on AssetMark's 13F filing for Q3 2026, filed 21 Oct 2026.